Galmed Pharmaceuticals Ltd. buy Royal Bank of Canada
Start price
06.11.24
/
50%
€6.40
Target price
06.11.25
€85.60
Performance (%)
-
End price
07.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Royal Bank of Canada from $80.00 to $92.00. They now have an "outperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
07.11.25
07.11.25
€79.74
07.11.26
07.11.26
-
19.09.24
19.09.24
Stopped prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
08.10.24
08.10.24
€72.86
08.10.25
08.10.25
-
09.10.25
09.10.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.26
07.08.24
07.08.24
€71.40
07.08.25
07.08.25
2361.54%
08.08.25
08.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.41
11.01.24
11.01.24
€63.93
11.01.25
11.01.25
1445.89%
12.01.25
12.01.25

